申请人:[en]DEBIOPHARM RESEARCH & MANUFACTURING S.A.
公开号:WO2022078566A1
公开(公告)日:2022-04-21
The present invention relates to compounds (reactive conjugates) for the chemical modification of therapeutic antibodies or proteins. The compounds enable the regioselective attachment of payloads to an antibody or antibody fragment in one single step, thereby producing a modified antibody or modified antibody fragment, which can be used for diagnosing, monitoring, imaging or treating disease.